Keratinocyte growth factor promotes epithelial survival and resolution in a human model of lung injury

American Journal of Respiratory and Critical Care Medicine

Volumn 189, Issue 12, 2014, Pages 1520-1529

  Shyamsundar, Murali ^a   McAuley, Daniel F ^a   Ingram, Rebecca J ^a   Gibson, David S ^a   O'Kane, Donal ^a   McKeown, Scott T ^a   Edwards, Alex ^a   Taggart, Cliff ^a   Elborn, Joseph S ^a   Calfee, Carolyn S ^b   Matthay, Michael A ^c   O'Kane, Cecilia M ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acute lung injury; Acute respiratory distress syndrome; Clinical trial; Keratinocyte growth factor; Lipopolysaccharide

Indexed keywords

C REACTIVE PROTEIN; GELATINASE B; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LIPOPOLYSACCHARIDE; PALIFERMIN; SURFACTANT PROTEIN D;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; LUNG INJURY; LUNG LAVAGE; MACROPHAGE; MALE; PHAGOCYTOSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VOLUNTEER; WOUND HEALING;

ACUTE LUNG INJURY; ACUTE RESPIRATORY DISTRESS SYNDROME; CLINICAL TRIAL; KERATINOCYTE GROWTH FACTOR; LIPOPOLYSACCHARIDE;

ACUTE LUNG INJURY; ADMINISTRATION, INTRAVENOUS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE; CELL PROLIFERATION; CELL SURVIVAL; DRUG ADMINISTRATION SCHEDULE; EPITHELIAL CELLS; FEMALE; FIBROBLAST GROWTH FACTOR 7; FIBROBLASTS; HUMANS; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PROTECTIVE AGENTS; PULMONARY ALVEOLI; RESPIRATORY DISTRESS SYNDROME, ADULT; WOUND HEALING; YOUNG ADULT;

EID: 84902682708     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201310-1892OC     Document Type: Article

References (46)

1. Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS; ARDS Defi nition Task Force. Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012;307:2526-2533.
2. Matthay MA, Ware LB, Zimmerman GA. The acute respiratory distress syndrome. J Clin Invest 2012;122:2731-2740.
3. Finch PW, Rubin JS, Miki T, Ron D, Aaronson SA. Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. Science 1989;245:752-755. (Pubitemid 19214010)
4. Jameson J, Ugarte K, Chen N, Yachi P, Fuchs E, Boismenu R, Havran WL. A role for skin gammadelta T cells in wound repair. Science 2002;296:747-749. (Pubitemid 34442005)
5. Zhang F, Nielsen LD, Lucas JJ, Mason RJ. Transforming growth factor-β antagonizes alveolar type II cell proliferation induced by keratinocyte growth factor. Am J Respir Cell Mol Biol 2004;31:679-686. (Pubitemid 39587499)
6. Portnoy J, Curran-Everett D, Mason RJ. Keratinocyte growth factor stimulates alveolar type II cell proliferation through the extracellular signal-regulated kinase and phosphatidylinositol 3-OH kinase pathways. Am J Respir Cell Mol Biol 2004;30:901-907. (Pubitemid 38736916)
7. Bao S, Wang Y, Sweeney P, Chaudhuri A, Doseff AI, Marsh CB, Knoell DL. Keratinocyte growth factor induces Akt kinase activity and inhibits Fas-mediated apoptosis in A549 lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 2005;288:L36-L42. (Pubitemid 40023884)
8. Galiacy S, Planus E, Lepetit H, Féréol S, Laurent V, Ware L, Isabey D, Matthay M, Harf A, d'Ortho MP. Keratinocyte growth factor promotes cell motility during alveolar epithelial repair in vitro. Exp Cell Res 2003;283:215-229. (Pubitemid 36269027)
9. Franco-Montoya M-L, Bourbon JR, Durrmeyer X, Lorotte S, Jarreau P-H, Delacourt C. Pulmonary effects of keratinocyte growth factor in newborn rats exposed to hyperoxia. Am J Physiol Lung Cell Mol Physiol 2009;297:L965-L976.
10. LaFemina MJ, Rokkam D, Chandrasena A, Pan J, Bajaj A, Johnson M, Frank JA. Keratinocyte growth factor enhances barrier function without altering claudin expression in primary alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol 2010;299:L724-L734.
11. Borok Z, Mihyu S, Fernandes VF, Zhang XL, Kim KJ, Lubman RL. KGF prevents hyperoxia-induced reduction of active ion transport in alveolar epithelial cells. Am J Physiol 1999;276:C1352-C1360. (Pubitemid 29323400)
12. Mason RJ, Pan T, Edeen KE, Nielsen LD, Zhang F, Longphre M, Eckart MR, Neben S. Keratinocyte growth factor and the transcription factors C/EBP α, C/EBP δ, and SREBP-1c regulate fatty acid synthesis in alveolar type II cells. J Clin Invest 2003;112:244-255. (Pubitemid 38056360)
13. Chang Y, Edeen K, Lu X, De Leon M, Mason RJ. Keratinocyte growth factor induces lipogenesis in alveolar type II cells through a sterol regulatory element binding protein-1c-dependent pathway. Am J Respir Cell Mol Biol 2006;35:268-274. (Pubitemid 44175328)
14. Ray P, Devaux Y, Stolz DB, Yarlagadda M, Watkins SC, Lu Y, Chen L, Yang XF, Ray A. Inducible expression of keratinocyte growth factor (KGF) in mice inhibits lung epithelial cell death induced by hyperoxia. Proc Natl Acad Sci USA 2003;100:6098-6103. (Pubitemid 36576937)
15. Baba Y, Yazawa T, Kanegae Y, Sakamoto S, Saito I, Morimura N, Goto T, Yamada Y, Kurahashi K. Keratinocyte growth factor gene transduction ameliorates acute lung injury and mortality in mice. Hum Gene Ther 2007;18:130-141. (Pubitemid 46446050)
16. Panos RJ, Bak PM, Simonet WS, Rubin JS, Smith LJ. Intratracheal instillation of keratinocyte growth factor decreases hyperoxia-induced mortality in rats. J Clin Invest 1995;96:2026-2033.
17. Ulrich K, Stern M, Goddard ME, Williams J, Zhu J, Dewar A, Painter HA, Jeffery PK, Gill DR, Hyde SC, et al. Keratinocyte growth factor therapy in murine oleic acid-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol 2005;288:L1179-L1192. (Pubitemid 40695445)
18. Welsh DA, Summer WR, Dobard EP, Nelson S, Mason CM. Keratinocyte growth factor prevents ventilator-induced lung injury in an ex vivo rat model. Am J Respir Crit Care Med 2000;162:1081-1086.
19. Nemzek JA, Ebong SJ, Kim J, Bolgos GL, Remick DG. Keratinocyte growth factor pretreatment is associated with decreased macrophage inflammatory protein-2alpha concentrations and reduced neutrophil recruitment in acid aspiration lung injury. Shock 2002;18:501-506.
20. Wu H, Suzuki T, Carey B, Trapnell BC, McCormack FX. Keratinocyte growth factor augments pulmonary innate immunity through epithelium-driven, GM-CSF-dependent paracrine activation of alveolar macrophages. J Biol Chem 2011;286:14932-14940.
21. Viget NB, Guery BP, Ader F, Nevière R, Alfandari S, Creuzy C, Roussel-Delvallez M, Foucher C, Mason CM, Beaucaire G, et al. Keratinocyte growth factor protects against Pseudomonas aeruginosa-induced lung injury. Am J Physiol Lung Cell Mol Physiol 2000;279:L1199-L1209. (Pubitemid 32009506)
22. Lee JW, Krasnodembskaya A, McKenna DH, Song Y, Abbott J, Matthay MA. Therapeutic effects of human mesenchymal stem cells in ex vivo human lungs injured with live bacteria. Am J Respir Crit Care Med 2013;187:751-760.
23. Lee JW, Fang X, Gupta N, Serikov V, Matthay MA. Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc Natl Acad Sci USA 2009;106:16357-16362.
24. Osslund TD, Syed R, Singer E, Hsu EW, Nybo R, Chen BL, Harvey T, Arakawa T, Narhi LO, Chirino A, et al. Correlation between the 1.6 A crystal structure and mutational analysis of keratinocyte growth factor. Protein Science 1998;7:1681-1690. (Pubitemid 29133173)
25. Shyamsundar M, McKeown STW, O'Kane CM, Craig TR, Brown V, Thickett DR, Matthay MA, Taggart CC, Backman JT, Elborn JS, et al. Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers. Am J Respir Crit Care Med 2009;179:1107-1114.
26. Shyamsundar M, O'Kane CM, Calfee C, McKeown ST, Taggart C, Matthay MA, McAuley DF. KGF enhances pulmonary production of pro-epithelial repair factors in a human in vivo model of acute lung injury. Thorax 2010;65:S102.
27. McAuley DF, Shyamsundar M, Calfee CS, McKeown ST, Taggart C, Matthay MA, O'Kane CM. KGF enhances the pulmonary production of epithelial repair factors following endotoxin induced lung inflammation and injury in human volunteers [abstract]. Am J Respir Crit Care Med 2011;183:A2383.
28. Perkins GD, Gao F, Thickett DR. In vivo and in vitro effects of salbutamol on alveolar epithelial repair in acute lung injury. Thorax 2008;63:215-220. (Pubitemid 351373715)
29. O'Kane CM, Boyle JJ, Horncastle DE, Elkington PT, Friedland JS. Monocyte-dependent fibroblast CXCL8 secretion occurs in tuberculosis and limits survival of mycobacteria within macrophages. J Immunol 2007;178:3767-3776. (Pubitemid 46417645)
30. Van Amersfoort ES, Van Strijp JA. Evaluation of a flow cytometric fluorescence quenching assay of phagocytosis of sensitized sheep erythrocytes by polymorphonuclear leukocytes. Cytometry 1994;17:294-301.
31. Kim SJ, Gershov D, Ma X, Brot N, Elkon KB. Opsonization of apoptotic cells and its effect on macrophage and T cell immune responses. Ann N Y Acad Sci 2003;987:68-78. (Pubitemid 36584008)
32. Presneill JJ, Harris T, Stewart AG, Cade JF, Wilson JW. A randomized phase II trial of granulocyte-macrophage colony-stimulating factor therapy in severe sepsis with respiratory dysfunction. Am J Respir Crit Care Med 2002;166:138-143. (Pubitemid 34765447)
33. Berclaz P-Y, Shibata Y, Whitsett JA, Trapnell BCGM-CSF. GM-CSF, via PU.1, regulates alveolar macrophage Fcgamma R-mediated phagocytosis and the IL-18/IFN-γ -mediated molecular connection between innate and adaptive immunity in the lung. Blood 2002;100:4193-4200. (Pubitemid 35396888)
34. Hohlfeld JM, Hoymann HG, Tschernig T, Fehrenbach A, Krug N, Fehrenbach H. Keratinocyte growth factor transiently alters pulmonary function in rats. J Appl Physiol (1985) 2004;96:704-710.
35. Cheng IW, Ware LB, Greene KE, Nuckton TJ, Eisner MD, Matthay MA. Prognostic value of surfactant proteins A and D in patients with acute lung injury. Crit Care Med 2003;31:20-27. (Pubitemid 36151144)
36. Hudock KM, Liu Y, Mei J, Marino RC, Hale JE, Dai N, Worthen GS. Delayed resolution of lung inflammation in Il-1rn-/- mice reflects elevated IL-17A/granulocyte colony-stimulating factor expression. Am J Respir Cell Mol Biol 2012;47:436-444.
37. Wiedermann FJ, Mayr AJ, Hobisch-Hagen P, Fuchs D, Schobersberger W. Association of endogenous G-CSF with anti-inflammatory mediators in patients with acute respiratory distress syndrome. J Interferon Cytokine Res 2003;23:729-736. (Pubitemid 38041444)
38. Yilmaz S, Inandiklioglu N, Yildizdas D, Subasi C, Acikalin A, Kuyucu Y, Bayram I, Topak A, Tanyeli A, Duruksu G, et al. Mesenchymal stem cell: does it work in an experimental model with acute respiratory distress syndrome? Stem Cell Rev 2013;9:80-92.
39. Chada M, Nögel S, Schmidt AM, Rückel A, Bosselmann S, Walther J, Papadopoulos T, von der Hardt K, Dötsch J, Rascher W, et al. Anakinra (IL-1R antagonist) lowers pulmonary artery pressure in a neonatal surfactant depleted piglet model. Pediatr Pulmonol 2008;43:851-857.
40. Frank JA, Pittet JF, Wray C, Matthay MA. Protection from experimental ventilator-induced acute lung injury by IL-1 receptor blockade. Thorax 2008;63:147-153. (Pubitemid 351236482)
41. O'Kane CM, McKeown ST, Perkins G, Bassford C, Gao-Smith F, Thickett DR, McAuley DF. Salbutamol upregulates MMP-9 secretion in the alveolar space in ARDS. Crit Care Med 2009;37:2242-2249.
42. Lanchou J, Corbel M, Tanguy M, Germain N, Boichot E, Theret N, Clement B, Lagente V, Malledant Y. Imbalance between matrix metalloproteinases (MMP-9 and MMP-2) and tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in acute respiratory distress syndrome patients. Crit Care Med 2003;31:536-542. (Pubitemid 36232952)
43. Vermeer PD, Denker J, Estin M, Moninger TO, Keshavjee S, Karp P, Kline JN, Zabner J. MMP9 modulates tight junction integrity and cell viability in human airway epithelia. Am J Physiol Lung Cell Mol Physiol 2009;296:L751-L762.
44. Albaiceta GM, Gutiérrez-Fernández A, Parra D, Astudillo A, García-Prieto E, Taboada F, Fueyo A. Lack of matrix metalloproteinase-9 worsens ventilator-induced lung injury. Am J Physiol Lung Cell Mol Physiol 2008;294:L535-L543. (Pubitemid 351468853)
45. Paine R III, Standiford TJ, Dechert RE, Moss M, Martin GS, Rosenberg AL, Thannickal VJ, Burnham EL, Brown MB, Hyzy RC. A randomized trial of recombinant human granulocyte-macrophage colony stimulating factor for patients with acute lung injury. Crit Care Med 2012;40:90-97.
46. Marnell L, Mold C, Du Clos TW. C-reactive protein: ligands, receptors and role in inflammation. Clin Immunol 2005;117:104-111. (Pubitemid 41407719)